Market closedNon-fractional

Ironwood Pharmaceuticals/IRWD

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ticker

IRWD

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Boston, United States

Employees

267

IRWD Metrics

BasicAdvanced
$989M
Market cap
-
P/E ratio
-$6.75
EPS
0.51
Beta
-
Dividend rate
$989M
0.51
0.825
0.767
-147.49
-208.891
5.39%
11.54%
-574.72%
2.35
-2.99
-2.96
6.57
-0.86%
-771.63%
1.25%
96.48%

What the Analysts think about IRWD

Analyst Ratings

Majority rating from 7 analysts.
Buy

IRWD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-5.48% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$75M
-36.34%
Net income
-$4.1M
310.00%
Profit margin
-5.48%
544.71%

IRWD Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 110.47%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$6.71
$0.09
-$0.01
-$0.02
-
Expected
$0.25
$0.16
$0.21
$0.19
$0.15
Surprise
-2,820.27%
-42.86%
-104.86%
-110.47%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ironwood Pharmaceuticals stock?

Ironwood Pharmaceuticals (IRWD) has a market cap of $989M as of July 05, 2024.

What is the P/E ratio for Ironwood Pharmaceuticals stock?

The price to earnings (P/E) ratio for Ironwood Pharmaceuticals (IRWD) stock is 0 as of July 05, 2024.

Does Ironwood Pharmaceuticals stock pay dividends?

No, Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Ironwood Pharmaceuticals dividend payment date?

Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders.

What is the beta indicator for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals (IRWD) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Ironwood Pharmaceuticals stock

Buy or sell Ironwood Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing